Tue, Jul 29, 2014, 7:35 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Teva Pharmaceutical Industries Limited Message Board

  • maxirnus maxirnus Sep 26, 2013 8:01 PM Flag

    Once again

    Once again – Teva's management comes today with great news that seems to be strong business news – but THE MARKET DOESN'T CARE AND EVEN TAKES THE STOCK PRICE DOWN.

    Did Teva's "top" management ever stopped and asked itself why the market behaves that way (for a long time now – for over seven (7) years) towards the news that comes out from the management of this company!!!???

    -------------------
    9:29AM Teva Pharma announces key data from its multiple sclerosis franchise will be featured in over 20 presentations at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis Oct 2-5, 2013 (TEVA) 38.16 : Co announced that key data from the co's multiple sclerosis (MS) franchise will be featured in over 20 presentations at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, October 2-5, 2013. Data presentations will provide new clinical insights on the effects of treatment with COPAXONE (glatiramer acetate injection) and the novel effects of laquinimod, Teva's investigational oral compound, when used to treat RRMS.
    -------------------

    *

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Nimwit, then buy some shares and stop crying like a baby all the time. Your lies have no relevance here.

      37$- 37.5$ is a solid bottom, but you have no brain to realize.

      Sentiment: Strong Buy

      • 2 Replies to greenmountain2014
      • Re: Nimwit, then buy some shares and stop crying like a baby all the time. Your lies have no relevance here. 37$- 37.5$ is a solid bottom, but you have no brain to realize."
        ----------------------------------------

        Gangrenemountain2014 - my post for Bottom is meant for you and your cheap posts as well:

        Please note Bottom (Gangrenemountain2014) that when one wants to be taken seriously – s/he has to provide facts and not just suffice in calling names and blaming others for misinformation – the very same thing s/he is doing in his less-than-informative posts!

        Copaxone is facing very tough competition – both from generics that will come to market in 2014 and ALSO from ORAL medicines that are already in the market – demonstrating excellent results that were published from their manufactures' tests. This is exactly what the writer I quoted meant when he so truly wrote: "Deadline exclusivity of Copaxone was known years ago, is anybody surprised? How was Teva and its glorious managers getting ready for this moment?", and no fancy and manipulating words of yours will ever succeed in changing that true fact.

        *

      • Told you guys 37.5$ was the bottom...

    • And the Teva stock price decline today (in spite of the good news) was taking place in an otherwise strong up market! :

      Dow Up 0.36%, Nasdaq Up 0.70%.

      Clearly IMHO - the market has nothing against Teva and its workers. It's the management's ugly greediness and lack of performance for so long that it is worried about.

      *

 
TEVA
54.32-0.08(-0.15%)Jul 29 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.